InterCure Ltd.
INCR
$1.10
$0.065.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 44.09% | 45.85% | -223.95% | -220.44% | -- |
| Total Depreciation and Amortization | 9.58% | 6.13% | 39.03% | 35.10% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 376.94% | 368.22% | 606.01% | 591.79% | -- |
| Change in Net Operating Assets | -42.06% | -43.88% | 96.28% | 96.38% | -- |
| Cash from Operations | 122.55% | 121.84% | 129.24% | 128.41% | -- |
| Capital Expenditure | 91.40% | 91.67% | -850.73% | -823.66% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -100.00% | 78.48% | 78.99% | -- |
| Divestitures | 1,192.40% | 1,159.82% | -- | -- | -- |
| Other Investing Activities | -97.42% | -97.50% | -108.45% | -108.21% | -- |
| Cash from Investing | -60.01% | -61.27% | -140.86% | -139.70% | -- |
| Total Debt Issued | -90.29% | -90.29% | -77.43% | -77.43% | -- |
| Total Debt Repaid | 85.21% | 85.21% | 47.68% | 47.68% | -- |
| Issuance of Common Stock | -95.59% | -95.59% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -69.33% | -69.33% | 14.39% | 14.39% | -- |
| Cash from Financing | -117.87% | -117.30% | 25.54% | 27.65% | -- |
| Foreign Exchange rate Adjustments | -14.00% | -10.00% | -233.33% | -233.33% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.49% | -109.19% | 65.37% | 66.35% | -- |